Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 9/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8851386 | 0.90 | SLC6A2 (0.31) | SLC6A2SLC6A4NOS3NOS1NOS2 | |
| SCHEMBL18233610 | 0.87 | PIK3CD (0.35) | PIK3CD | |
| SCHEMBL8851169 | 0.79 | PRMT3 (0.39) | NOS3NOS1NOS2 | |
| SCHEMBL8851159 | 0.79 | SLC6A2 (0.38) | SLC6A2SLC6A4NOS3NOS1NOS2 | |
| SCHEMBL18233621 | 0.79 | PIK3CD (0.55) | PIK3CD | |
| SCHEMBL8851136 | 0.79 | PIK3CD (0.31) | PIK3CD | |
| SCHEMBL8851458 | 0.78 | SLC6A2 (0.41) | SLC6A2SLC6A4NOS3NOS1NOS2 | |
| SCHEMBL8852165 | 0.76 | GNAI3 (0.34) | SLC6A2SLC6A4NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL5572628 | 0.76 | NOS3 (0.38) | SLC6A2SLC6A4NOS3NOS1NOS2 | |
| SCHEMBL13766691 | 0.76 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5618814-A | Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds | DR. KARL THOMAE GMBH (DE) | 1997-04-08 | — | — | US | disclosed |